Global Cord Blood Corporation (CORBF)
OTCMKTS · Delayed Price · Currency is USD
1.100
0.00 (0.00%)
Nov 21, 2025, 4:00 PM EST
Global Cord Blood Market Cap
Global Cord Blood has a market cap or net worth of $147.31 million as of November 21, 2025. Its market cap has decreased by -27.15% in one year.
Market Cap
147.31M
Enterprise Value
n/a
Revenue
196.10M
Ranking
n/a
PE Ratio
1.69
Stock Price
$1.10
Market Cap Chart
Since July 1, 2009, Global Cord Blood's market cap has decreased from 968.15M to 147.31M, a decrease of -84.78%. That is a compound annual growth rate of -10.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 147.31M | -26.67% |
| Dec 31, 2024 | 200.87M | 22.95% |
| Dec 29, 2023 | 163.38M | -67.92% |
| Dec 31, 2021 | 509.30M | 12.94% |
| Dec 31, 2020 | 450.95M | -25.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 554.98M |
| Glass House Brands | 520.88M |
| American Oncology Network | 412.69M |
| Tian'an Technology Group | 386.45M |
| Northwest Biotherapeutics | 382.71M |
| CytoDyn | 378.68M |
| Nika Pharmaceuticals | 311.89M |